In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inveresk Research Group Inc.

Division of Charles River Laboratories International Inc.
www.inveresk.com

Latest From Inveresk Research Group Inc.

Asia On The Move: CFDA Deputy Commissioner Moves To Sichuan

April always brings with it a flurry of personnel changes. China FDA deputy commissioner Yin Li is heading to a leadership position in Sichuan province, Takeda COO Christophe Weber has become CEO and Otsuka has a new chairman, while personnel changes also took place at Aslan and CROs WuXiPRA and George Clinical.

BioPharmaceutical Japan

Rheoscience AS

Rheoscience focuses on target discovery in diabetes, obesity and the metabolic syndrome. To fund its target discovery activities, the company also provides preclinical research services, offering access to a range of novel animal models for validating experimental data and for use in the preclinical and early clinical phases of the drug discovery process.
BioPharmaceutical Europe

Deal Statistics Quarterly, Q2 2002

In Vivo presents another installment of our quarterly review of dealmaking--in this case April through June 2002. Our data come from Windhover's Strategic Transactions Database. We include medical device financings by deal type; diagnostic financings by industry segment; pharma and biotech alliances by therapeutic category and industry segment; pharma and biotech financings by market segment, and pharma and biotech M&A.
BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Pharmacogenetics-Pharmacogenomics
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Inveresk Research International Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Charles River Laboratories International Inc.
  • Senior Management
  • Walter S Nimmo, CEO
    DJ Paul E Cowan, CFO
    Nicholas J Thornton, Head, Corp. Dev.
  • Contact Info
  • Inveresk Research Group Inc.
    Phone: (919) 460-9005
    11000 Weston Pkwy., Ste. 100
    Cary, NC 27513
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register